TCR2 Therapeutics Langfristige Verbindlichkeiten 2011-2026 | TCRR

Langfristige Verbindlichkeiten Jährlich TCR2 Therapeutics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	807 K	546 K	210 M	47.1 M	29.2 M	-	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
210 M	546 K	57.5 M

Langfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name	Langfristige Verbindlichkeiten	Preis	% 24h	Marktkapitalisierung	Land
FSD Pharma HUGE	79.1 K	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	158 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
AstraZeneca PLC AZN	34.7 B	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	876 K	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	7.32 M	-	0.74 %	$ 768 M	Israel
Galera Therapeutics GRTX	64 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	645 K	-	-18.52 %	$ 27.3 M	Britain
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Celyad Oncology SA CYAD	4.97 M	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
Arcturus Therapeutics Holdings ARCT	30.4 M	$ 6.82	1.94 %	$ 187 M	Israel
Generation Bio Co. GBIO	132 M	-	-	$ 344 M	USA
IMV IMV	8.95 M	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
BioNTech SE BNTX	622 M	$ 90.36	2.93 %	$ 21.8 B	Germany
Autolus Therapeutics plc AUTL	50.6 M	$ 1.62	-0.61 %	$ 431 M	Britain
Ayala Pharmaceuticals AYLA	497 K	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	1.06 M	-	-4.36 %	$ 27 M	USA
Compugen Ltd. CGEN	31.3 M	$ 2.71	-0.92 %	$ 253 M	Israel
Anika Therapeutics ANIK	26.1 M	$ 15.14	2.16 %	$ 217 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	14 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 3.39	2.91 %	$ 5.58 M	Israel
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Coherus BioSciences CHRS	189 M	$ 1.51	2.03 %	$ 177 M	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	167 M	$ 20.47	4.97 %	$ 2.6 B	USA
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	4.59 M	-	10.36 %	$ 9.8 M	USA
Applied Therapeutics APLT	797 K	-	-	$ 8.42 M	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA